Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

被引:19
|
作者
Heidrich, Vitor [1 ,2 ]
Bruno, Julia S. [1 ]
Knebel, Franciele H. [1 ]
de Molla, Vinicius C. [3 ,4 ]
Miranda-Silva, Wanessa [1 ]
Asprino, Paula F. [1 ]
Tucunduva, Luciana [3 ]
Rocha, Vanderson [3 ,5 ,6 ]
Novis, Yana [3 ]
Arrais-Rodrigues, Celso [3 ,4 ]
Fregnani, Eduardo R. [3 ]
Camargo, Anamaria A. [1 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Dept Oncol Clin & Expt, Sao Paulo, Brazil
[5] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[6] Churchill Hosp, Natl Hlth Serv Blood & Transplant, Oxford, England
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
巴西圣保罗研究基金会;
关键词
oral microbiota; supragingival plaque; microbiome dysbiosis; acute GVHD; allogeneic HSCT; bone marrow transplant; GUT MICROBIOME; ORAL MICROBIOME; COLONIZATION; INHIBITION; DIVERSITY; PATHOGENS; DIAGNOSIS; BACTERIA; PROJECT; GVHD;
D O I
10.3389/fimmu.2021.692225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute graft-versus-host disease (aGVHD) is one of the major causes of death after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recently, aGVHD onset was linked to intestinal microbiota (IM) dysbiosis. However, other bacterial-rich gastrointestinal sites, such as the mouth, which hosts several distinctive microbiotas, may also impact the risk of GVHD. The dental biofilm microbiota (DBM) is highly diverse and, like the IM, interacts with host cells and modulates immune homeostasis. We characterized changes in the DBM of patients during allo-HSCT and evaluated whether the DBM could be associated with the risk of aGVHD. DBM dysbiosis during allo-HSCT was marked by a gradual loss of bacterial diversity and changes in DBM genera composition, with commensal genera reductions and potentially pathogenic bacteria overgrowths. High Streptococcus and high Corynebacterium relative abundance at preconditioning were associated with a higher risk of aGVHD (67% vs. 33%; HR = 2.89, P = 0.04 and 73% vs. 37%; HR = 2.74, P = 0.04, respectively), while high Veillonella relative abundance was associated with a lower risk of aGVHD (27% vs. 73%; HR = 0.24, P < 0.01). Enterococcus faecalis bloom during allo-HSCT was observed in 17% of allo-HSCT recipients and was associated with a higher risk of aGVHD (100% vs. 40%; HR = 4.07, P < 0.001) and severe aGVHD (60% vs. 12%; HR = 6.82, P = 0.01). To the best of our knowledge, this is the first study demonstrating that DBM dysbiosis is associated with the aGVHD risk after allo-HSCT.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Complexity of Acute Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation at the Stage of the Occurrence and Risk Factors
    Lang, Tao
    Wang, Zengsheng
    Xu, Yanfang
    Wang, Yichun
    Li, Yan
    An, Li
    Mao, Min
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 68 - 68
  • [22] Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Weissinger, Eva M.
    Schiffer, Eric
    Hertenstein, Bernd
    Ferrara, James L.
    Holler, Ernst
    Stadler, Michael
    Kolb, Hans-Jochem
    Zander, Axel
    Zurbig, Petra
    Kellmann, Markus
    Ganser, Arnold
    BLOOD, 2007, 109 (12) : 5511 - 5519
  • [23] Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in paediatric patients
    Kim, M. S.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S112 - S113
  • [24] Association Between MDSCs and Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Qifa, Sr.
    Ling, Yiwen
    Fan, Zhiping
    Zhang, Yu
    Huang, Fen
    Wu, Xiuli
    Xuan, Li
    Wu, Meiqing
    BLOOD, 2011, 118 (21) : 1737 - 1738
  • [25] Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zupan, IP
    Zver, S
    Pretnar, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2931 - 2933
  • [26] Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Servais, Sophie
    Beguin, Yves
    Delens, Loic
    Ehx, Gregory
    Fransolet, Gilles
    Hannon, Muriel
    Willems, Evelyne
    Humblet-Baron, Stephanie
    Belle, Ludovic
    Baron, Frederic
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 957 - 972
  • [27] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
  • [28] Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Reddy, P.
    Johnson, K.
    Uberti, J. P.
    Reynolds, C.
    Silver, S.
    Ayash, L.
    Braun, T. M.
    Ratanatharathorn, V.
    BONE MARROW TRANSPLANTATION, 2006, 38 (05) : 351 - 357
  • [29] Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Sairafi, Darius
    Stikvoort, Arwen
    Gertow, Jens
    Mattsson, Jonas
    Uhlin, Michael
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [30] Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics
    Gray, Ashley N.
    Defilipp, Zachariah
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 484 - 491